Targeting Bruton's tyrosine kinase expression levels through microRNAs in chronic lymphocytic leukemia treatment

被引：1
作者：
Singh, Simar Pal [1 ,2 ,3 ]
Rip, Jasper [1 ]
Hendriks, Rudi W. [1 ]
机构：
[1] Erasmus MC, Dept Pulm Med, Room Ee2251a,POB 2040, NL-3000 CA Rotterdam, Netherlands
[2] Erasmus MC, Dept Immunol, Rotterdam, Netherlands
[3] Erasmus MC, Post Grad Sch Mol Med, Rotterdam, Netherlands
来源：
TRANSLATIONAL CANCER RESEARCH | 2017年 / 6卷
关键词：
B-CELL ACTIVATION; BTK; IBRUTINIB; INHIBITOR; MECHANISMS; MIR-155; DISEASE; RNA;
D O I：
10.21037/tcr.2017.04.06
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S502 / S507
页数：6
相关论文
共 25 条
  • [11] BTK Signaling in B Cell Differentiation and Autoimmunity
    Corneth, Odilia B. J.
    Wolterink, Roel G. J. Klein
    Hendriks, Rudi W.
    [J]. B CELL RECEPTOR SIGNALING, 2016, 393 : 67 - 105
  • [12] Distinct and Overlapping Functions of TEC Kinase and BTK in B Cell Receptor Signaling
    de Bruijn, Marjolein J. W.
    Rip, Jasper
    van der Ploeg, Esmee K.
    van Greuningen, Lars W.
    Ta, Van T. B.
    Kil, Laurens P.
    Langerak, Anton W.
    Rimmelzwaan, Guus F.
    Ellmeier, Wilfried
    Hendriks, Rudi W.
    Corneth, Odilia B. J.
    [J]. JOURNAL OF IMMUNOLOGY, 2017, 198 (08) : 3058 - 3068
  • [13] Ibrutinib is an irreversible molecular inhibitor of ITK driving a Th1-selective pressure in T lymphocytes
    Dubovsky, Jason A.
    Beckwith, Kyle A.
    Natarajan, Gayathri
    Woyach, Jennifer A.
    Jaglowski, Samantha
    Zhong, Yiming
    Hessler, Joshua D.
    Liu, Ta-Ming
    Chang, Betty Y.
    Larkin, Karilyn M.
    Stefanovski, Matthew R.
    Chappell, Danielle L.
    Frissora, Frank W.
    Smith, Lisa L.
    Smucker, Kelly A.
    Flynn, Joseph M.
    Jones, Jeffrey A.
    Andritsos, Leslie A.
    Maddocks, Kami
    Lehman, Amy M.
    Furman, Richard
    Sharman, Jeff
    Mishra, Anjali
    Caligiuri, Michael A.
    Satoskar, Abhay R.
    Buggy, Joseph J.
    Muthusamy, Natarajan
    Johnson, Amy J.
    Byrd, John C.
    [J]. BLOOD, 2013, 122 (15) : 2539 - 2549
  • [14] Accumulation of miR-155 and BIC RNA in human B cell lymphomas
    Eis, PS
    Tam, W
    Sun, LP
    Chadburn, A
    Li, ZD
    Gomez, MF
    Lund, E
    Dahlberg, JE
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2005, 102 (10) : 3627 - 3632
  • [15] Targeting Bruton's tyrosine kinase in B cell malignancies
    Hendriks, Rudi W.
    Yuvaraj, Saravanan
    Kil, Laurens P.
    [J]. NATURE REVIEWS CANCER, 2014, 14 (04) : 219 - 232
  • [16] The Bruton tyrosine kinase inhibitor PCI-32765 blocks B-cell activation and is efficacious in models of autoimmune disease and B-cell malignancy
    Honigberg, Lee A.
    Smith, Ashley M.
    Sirisawad, Mint
    Verner, Erik
    Loury, David
    Chang, Betty
    Li, Shyr
    Pan, Zhengying
    Thamm, Douglas H.
    Miller, Richard A.
    Buggy, Joseph J.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2010, 107 (29) : 13075 - 13080
  • [17] Kil LP, 2013, AM J BLOOD RES, V3, P71
  • [18] Btk levels set the threshold for B-cell activation and negative selection of autoreactive B cells in mice
    Kil, Laurens P.
    de Bruijn, Marjolein J. W.
    van Nimwegen, Menno
    Corneth, Odilia B. J.
    van Hamburg, Jan Piet
    Dingjan, Gemma M.
    Thaiss, Friedrich
    Rimmelzwaan, Guus F.
    Elewaut, Dirk
    Delsing, Dianne
    van Loo, Pieter Fokko
    Hendriks, Rudi W.
    [J]. BLOOD, 2012, 119 (16) : 3744 - 3756
  • [19] microRNAs and the immune response
    Tsitsiou, Eleni
    Lindsay, Mark A.
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2009, 9 (04) : 514 - 520
  • [20] Targeting Signaling Pathways in Chronic Lymphocytic Leukemia
    Muggen, Alice F.
    Singh, Simar P.
    Hendriks, Rudi W.
    Langerak, Anton W.
    [J]. CURRENT CANCER DRUG TARGETS, 2016, 16 (08) : 669 - 688
123